We came across a bullish thesis on Pfizer Inc. on Investing With Purpose’s Substack. In this article, we will summarize the bulls’ thesis on PFE. Pfizer Inc.’s share was trading at $24.15 as of September 18th. PFE’s trailing and forward P/E were 12.78 and 7.74 respectively according to Yahoo Finance.
M. A. Arkhipov/Shutterstock.com
Pfizer (PFE) has experienced a sharp post-COVID revenue normalization, with sales retreating from a 2022 peak of ~$100 billion to $58 billion in 2023,...
